Establishment of rapid molecular diagnoses of micrometastases of sentinel lymph node and its clinical application
Establishment of rapid molecular diagnoses of micrometastases of sentinel lymph node and its clinical application
批准号:
12557100
负责人:
MORI Masaki
金额:
$8.26万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
我们的研究表明;1. 作为消化器官癌手术时扩张指标或淋巴结清扫减少指标的前哨淋巴结(SLN)的鉴别;3.肿瘤微转移的诊断;3 .外科手术中快速基因诊断方法的发展;SLN对预后影响的评价前哨淋巴结(SLN)的识别,作为消化器官癌手术时的扩张指标,或减少淋巴结清扫。常规病理诊断估计52例胃癌中30例淋巴结转移阴性的微转移情况。在评价7号淋巴结是否可作为SLN时,得出7号淋巴结可反映其他2组淋巴结转移情况的结果(假阴性率:16.7%,正确率:88.9%)。研究了苏木精染色、免疫组化、RT-PCR等方法对sln微转移的诊断。在常规HE染色评估的基础上,结合免疫组织化学和RT-PCR方法,成功地提高了SLN转移阳性病例的检出率(16),SLN的检出率:95→98%;[j] .中华医学会。2000)。外科手术中快速分子诊断方法的发展。采用常规RT-PCR方法获得基因诊断的诊断结果需要约8小时。我们成功地缩短了大约75分钟和时间,尽管目前通过改进RNA取样过程和引入实时PCR来获得诊断结果。当从新的RNA取样过程到实时PCR法的cDNA合成和检测技术正在建立时,估计获得诊断结果大约需要50分钟。评价SLN对预后的影响对28例7号淋巴结转移情况(RT-PCR诊断)进行分析,其中临床I期和II期的52例胃癌患者行根治性A切除。结果显示,7号淋巴结转移阳性患者预后较阴性患者差。少
英文摘要
Our study has revealed that ; 1. Identification of sentinel lymph node (SLN) used as index of expansion at time of operation of digestive organ cancer or reduction of lymph nodes dissection, 2. Diagnosis of micrometastases of SLN, 3. Development of rapid gene-diagnosis method while surgical operation, 4. Evaluation of influence of SLN affection on prognosis.1. Identification of sentinel lymph node (SLN) used as index of expansion at time of digestive organ cancer operation, or reduction of lymph nodes dissection.The conventional pathological diagnosis estimated the micrometastases situation of 30 cases that were lymph node metastases negative among 52 stomach cancer cases. The result in which #7 lymph node may reflect other 2 group lymph node may reflect other 2 group lymph nodes metastases situations in evaluation whether #7 lymph node may serve as SLN was obtaind (rate of false negative : 16.7 % and rate of accuracy : 88.9 %).2. Diagnosis of micrometastases of SLNThe hematoxylin-eosi … More n (HE) staining, the immunohistochemistry, and RT-PCR method have been examined. Then, it succeeded in raising the rate of detection of the cases, that is positive of metastases of SLN using together evaluation by the immunohistochemistry and RT-PCR method in addition to evaluation only using the conventional HE staining method (16 rate of SLN identification : 95→98 % ; Int. J. Oncol. 2000).3. Development of rapid molecular diagnosis method while surgical operation.It had required for obtaining a diagnostic result of the gene diagnosis using the conventional RT-PCR method for about 8 hours. We succeeded in shortening about 75 minutes and time, although a diagnostic result is obtained by an improvement of a RNA sampling process and introduction of real time PCR at present. When the technique from a new RNA sampling process to cDNA composition and delection by the real-time PCR method is now under establishment, it is presumed that it will be about 50 minutes obtaining a diagnostic result.4. Evaluation of influence SLN affects prognosisAnalysis about the metastases situation (it diagnoses in RT-PCR method) of #7 lymph node was performed about 28 cases in which were the clinical stage I and II performed curability A resection among 52 stomach cancer cases. It revealed that the cases of #7 lymph node metastases positive become poor prognosis compared with negative cases. Less
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Etoh T., Utsunomiya T., et al.: "Clinical significance of K-ras mutations in irtraoperative tumor drainage blood from patients with colorectal carcinoma"Ann Surg Oncol. 6. 407-4412 (2001)
Etoh T.、Utsunomiya T. 等人:“结直肠癌患者术中肿瘤引流血中 K-ras 突变的临床意义”Ann Surg Oncol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsuyama A., and Shibuta K., et al: "Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer"Cancer Res. 61. 5714-5717 (2001)
Matsuyama A. 和 Shibuta K. 等人:“肝癌衍生生长因子与食道癌对辐射的敏感性降低有关”Cancer Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
片岡明美 他: "ナビゲーションサージャリー 色素法による乳癌sentinel nodes生検"手術. 54(12). 1725-1732 (2000)
Akemi Kataoka 等:“使用染色法进行乳腺癌前哨淋巴结活检”Surgery 54(12) (2000)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsuyama A., Shibuta K., et al.: "Hepatoma-derived growth factor is associated with reduced sensitivity to irradiation in esophageal cancer"Cancer Res. 61. 5714-5717 (2001)
Matsuyama A.、Shibuta K. 等人:“肝癌来源的生长因子与食道癌对辐射的敏感性降低有关”Cancer Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 19 条
Achievement of highly accurate diagnosis of early pancreatic cancer in Japanese patients through a comprehensive/integrated approach
-
批准号:15H05791
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$127.96万
-
财政年份:2015
-
负责人:MORI Masaki
-
依托单位:
Noveltechnology for imuse cell induction.
-
批准号:23659648
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2011
-
负责人:MORI Masaki
-
依托单位:
Comparison research on building strategy of overseas Chinese enterprises under economic environments in three east Asian countries
-
批准号:22730318
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$1.33万
-
财政年份:2010
-
负责人:MORI Masaki
-
依托单位:
Exploration of high-energy emission mechanism of the Galactic objects with Fermi Gamma-ray Space Telescope Data
-
批准号:22540315
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.66万
-
财政年份:2010
-
负责人:MORI Masaki
-
依托单位:
Comprehensive Analysis for Improvement of the Therapeutic Outcome against Esophageal Cancer by the High-Precision Molecular and Genetic Evaluation
-
批准号:21229015
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$135.37万
-
财政年份:2009
-
负责人:MORI Masaki
-
依托单位:
Exploration of Galactic Cosmic-ray Origin with High Angular/Energy Resolution TeV Gamma-ray Observation
-
批准号:17204015
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$31.62万
-
财政年份:2005
-
负责人:MORI Masaki
-
依托单位:
Analyses of disease resistance mechanism by rice acyltransferase family
-
批准号:17580087
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2005
-
负责人:MORI Masaki
-
依托单位:
Study of molecular-genetics, and molecular epidemiology for developing treatment of esophageal cancer
-
批准号:17109013
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$71.72万
-
财政年份:2005
-
负责人:MORI Masaki
-
依托单位:
Establishment of melecular-based diagnositics for esophageal cancer
-
批准号:15390398
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.47万
-
财政年份:2003
-
负责人:MORI Masaki
-
依托单位:
Gene therapy for chronic granulomatous disease combined with in vivo expansion of transduced hematopoietic cells.
-
批准号:14570993
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:MORI Masaki
-
依托单位:
Simultaneous observation of TeV time-variable objects and gamma-ray burst afterglows with an optical telescope
-
批准号:14540248
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.66万
-
财政年份:2002
-
负责人:MORI Masaki
-
依托单位:
Simultaneous observation of time variable TeV gamma-ray objects in optical wavelength and monitoring of night sky
-
批准号:12640254
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2000
-
负责人:MORI Masaki
-
依托单位:
Universe Seen From Very High Energy Eyes
-
批准号:11CE2004
-
项目类别:Grant-in-Aid for COE Research
-
资助金额:$943.02万
-
财政年份:1999
-
负责人:MORI Masaki
-
依托单位:
Clinical significance of molecular detection of carcinoma cells
-
批准号:10470260
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.19万
-
财政年份:1998
-
负责人:MORI Masaki
-
依托单位:
Molecular detection of cancer cells by RT-PCR
-
批准号:08457326
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.38万
-
财政年份:1996
-
负责人:MORI Masaki
-
依托单位:
Analysis of metastasis or morphology related genes in gastrolintestinal carcinoma
-
批准号:05671069
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1993
-
负责人:MORI Masaki
-
依托单位:
Preoperative Hyperthermochemoradiotherapy for Patients with Rectal Cancer
-
批准号:63570641
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1988
-
负责人:MORI Masaki
-
依托单位:
海外基金